Cybin (NYSE American: CYBN) (NEO: CYBN) shared promising 12-month efficacy data from its Phase 2 study of CYB003, a proprietary deuterated ps ...

Depression and anxiety rank among the top global health challenges. Since 1990, these disorders have surged, placing them in ...

On a sunny day in July, while other Bay Area kids were playing at camps or water parks, 8-year-old Charlotte O’Neill was leaning back in a reclining chair in a small, carpeted San Jose office room.

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

One study suggests these drugs could increase depression risk in heart attack survivors who retained normal heart pumping ...

A compassionate, multidisciplinary approach can help manage one of the most complex challenges nursing homes and other long-term care providers face.

Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced that it will present posters highlighting new ...

"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can ...

SHOPPERS have gone wild for a new Krispy Kreme doughnut flavour inspired by an American favourite. Asda customers were delighted to find the "yummy" treats as they cried "we need these". The ...

Sixty-eight of these women were randomised between the three treatment groups. Results: Mean scores on the Beck Depression Inventory (BDI-II) at entry were in the moderate-to-severe range.